Position in GILD
as of Jun 30, 2026
· filed Jul 27, 2026
Position Value
$4,847,034
-$3,956,272 QoQ
Shares Held
38,365
-39.3% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
1.46%
of 13F equity value
Holder Rank
#587
of 2,266 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Derivatives in GILD
reported options exposure · as of Jun 30, 2026CallValue
$25,268,000
CallShares
200,000
PutValue
$25,268,000
PutShares
200,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026ADAPT Investment Managers SA holds $16,063,088 across 2 Drug Manufacturers - General names. GILD ranks #2 (30.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PFE |
Pfizer Inc
|
465,783 | $11,216,054 | |
| 2 | GILD |
Gilead Sciences, Inc.
This page
|
38,365 | $4,847,034 |
All Filings in GILD
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $25,268,000 | 200,000 | Put | Sole | 2026-07-27 | |
| 2026-06-30 | $25,268,000 | 200,000 | Call | Sole | 2026-07-27 | |
| 2026-06-30 | $4,847,034 | 38,365 | Shares | Sole | 2026-07-27 | |
| 2026-03-31 | $27,874,000 | 200,000 | Put | Sole | 2026-05-15 | |
| 2026-03-31 | $13,937,000 | 100,000 | Call | Sole | 2026-05-15 | |
| 2026-03-31 | $8,803,306 | 63,165 | Shares | Sole | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||